| ARCELLX Arcellx, Inc.
97208593 07 Jan 2022 | on 06 Feb 2024
| Biological preparations for the treatment of cancer using genetically ... Class 005 Class 005 Pharmaceutical Products The color(s) navy blue, purple, and blue is/are claimed as a feature of the mark. | | | ARCELLX Arcellx, Inc.
97144451 26 Nov 2021 | on 06 Feb 2024
| Biological preparations for the treatment of cancer using genetically ... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating cancer; pharmaceutical preparations for the purpose of binding ligands using receptors for treating cancer; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating cancer | | | SPARX PROTEIN Arcellx, Inc.
88861317 06 Apr 2020 | on 10 Dec 2024 | Pharmaceutical preparations for targeting tissues based on select tiss... Class 005 Class 005 Pharmaceutical Products The mark consists of the phrase "SPARX PROTEIN" in stylized form. | | | SPARX PROTEINS Arcellx, Inc.
88861339 06 Apr 2020 | on 10 Dec 2024 | Pharmaceutical preparations for targeting tissues based on select tiss... Class 005 Class 005 Pharmaceutical Products The mark consists of the phrase "SPARX PROTEINS" in stylized form. | | | SPARX Arcellx, Inc.
87909928 07 May 2018 | on 26 Nov 2024 | Biological preparations for the treatment of cancer using polypeptides... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of cancer using polypeptides and genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors; pharmaceutical preparations for immunotherapy using polypeptides and genetically engineered cells; pharmaceutical preparations for immune cell therapy using polypeptides and genetically engineered cells | | | ARC-T Arcellx, Inc.
97144441 26 Nov 2021 | on 29 Jun 2023 | Biological preparations for the treatment of hematological and solid t... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of hematological and solid tumor cancers using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for treating hematological and solid tumor cancers; pharmaceutical preparations for the purpose of binding ligands using receptors for treating hematological and solid tumor cancers; pharmaceutical preparations for immunotherapy using genetically engineered cells for treating hematological and solid tumor cancers | | | ARC-SPARX Arcellx, Inc.
97144474 26 Nov 2021 | on 29 Jun 2023 | Biological preparations for the treatment of hematological and solid t... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | ARCELLX Arcellx, Inc.
87196810 07 Oct 2016 | on 03 Feb 2022 | Biological preparations for the treatment of cancer using genetically ... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using receptors; pharmaceutical preparations for immunotherapy using genetically engineered cells | | | ARC-T Arcellx, Inc.
87909808 07 May 2018 | on 03 Jan 2022 | Biological preparations for the treatment of cancer using polypeptides... Class 005 Class 005 Pharmaceutical Products Biological preparations for the treatment of cancer using polypeptides and genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors; pharmaceutical preparations for immunotherapy using polypeptides and genetically engineered cells; pharmaceutical preparations for immune cell therapy using polypeptides and genetically engineered cells | | 
